Home
Live Updates
DermTech Announces Additional Restructuring Actions to Focus on Revenue Growth and Streamline Operations : comparemela.com
DermTech Announces Additional Restructuring Actions to Focus on Revenue Growth and Streamline Operations
- Ongoing emphasis on growing revenue for the DermTech Melanoma Test
- Approximately $40 million in total operating expense reductions compared to fiscal 2022 resulting from all restructuring...
Related Keywords
,
Bret Christensen ,
Nasdaq ,
Dermtech Inc ,
Dermtech Melanoma Test ,
Markets ,
comparemela.com © 2020. All Rights Reserved.